Search Results - "Starnecker, F"

Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas by Schön, S., Cabello, J., Liesche-Starnecker, F., Molina-Romero, M., Eichinger, P., Metz, M., Karimov, I., Preibisch, C., Keupp, J., Hock, A., Meyer, B., Weber, W., Zimmer, C., Pyka, T., Yakushev, I., Gempt, J., Wiestler, B.

“…Purpose Imaging glioma biology holds great promise to unravel the complex nature of these tumors. Besides well-established imaging techniques such…”
Get full text

Tissue-engineering acellular scaffolds-The significant influence of physical and procedural decellularization factors by Starnecker, F, König, F, Hagl, C, Thierfelder, N

“…The importance of decellularized medical products has significantly increased during the last years. In this paper, we evaluated the effects of selected…”
Get full text

Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy by Gempt, J., Withake, F., Aftahy, A.K., Meyer, H.S., Barz, M., Delbridge, C., Liesche-Starnecker, F., Prokop, G., Pfarr, N., Schlegel, J., Meyer, B., Zimmer, C., Menze, B.H., Wiestler, B.

“…Intratumoral heterogeneity at the cellular and molecular level is a hallmark of glioblastoma (GB) that contributes to treatment resistance and poor clinical…”
Get full text

P12.04.B MGMT-STATUS OF TUMOR INFILTRATING MACROPHAGES IN HUMAN GLIOBLASTOMA by Zeiler, A, Liesche-Starnecker, F, Delbridge, C, Wagner, A, Gempt, J, Schlegel, J

“…Abstract BACKGROUND Glioblastomas are the most prevalent malignant brain tumors in adults, with a frequency ranging from 0.59 to 3.69 in the western world…”
Get full text

Comparative outcomes of drug-coated balloon angioplasty versus second-generation drug-eluting stent for in-stent restenosis: a real-world data analysis by Krefting, J, Krueger, N, Graesser, C, Schmieder, R, Starnecker, F, Kufner, S, Cassese, S, Kastrati, A, Schunkert, H, Von Scheidt, M, Wiebe, J

“…Abstract Background Coronary in-stent restenosis (ISR) poses a significant challenge in interventional cardiology, with optimal treatment strategies being the…”
Get full text

Real-world evidence supports superior efficacy of prasugrel over ticagrelor in individuals with acute coronary syndrome by Kruger, N, Krefting, J, Kessler, T, Starnecker, F, Meyer-Lindemann, U, Storz, T, Manea, I, Krase, P, Offenborn, F, Kastrati, A, Cassese, S, Schunkert, H, Scheidt, M

“…Abstract Background In patients with acute coronary syndrome (ACS) undergoing invasive treatment, ticagrelor and prasugrel are guideline-recommended P2Y12…”
Get full text

P11.22.A Prognostic and predictive relevance of immunohistochemically determined p53 mutation in glioblastoma by Kempter, J, Gempt, J, Wiestler, B, Combs, S E, Schlegel, J, Liesche-Starnecker, F, Schmidt-Graf, F

“…Abstract Background It can be expected that molecular biomarkers will increasingly affect clinical decisions and lead to the development of more personalized…”
Get full text